EGFR-targeted therapies based on antibody engineering and nanotechnology for colorectal cancer

Biomaterials 2026

View at publisher

Authors: Xingxing Shang, Ziyi Zhang, Tao Wu, Yanyang Nan, Dianwen Ju

DOI: 10.1016/j.biomaterials.2026.124210

Cited by: 1

References: 139

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Nanoparticle-Based Drug Delivery HER2/EGFR in Cancer Research

References 139